Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVP Chemotherapy and Radiotherapy in Frail Elderly Patients With Non-Hodgkin's Lymphoma
NCT00039351Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 2002
- Primary completion
- Jan 2005
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 7
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide, vincristine and prednisone in non-Hodgkin lymphoma (NHL), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Complete Remission Rate. Started Mar 2002; status: completed.
02
Drugs
cyclophosphamidevincristineprednisone
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00039351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00039351.